NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments
Stock Information for NRX Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.